Board Meeting28 Oct 2026, 09:12 pm
Aarti Pharmalabs Board Approves Unaudited Financial Results; Appoints New CFO
AI Summary
Aarti Pharmalabs Ltd announced that its Board of Directors, in a meeting held on October 28, 2026, approved the unaudited financial results for the quarter and half-year ended September 30, 2026. The company also noted the resignation of Shri. Piyush Lakhani as Chief Financial Officer (CFO) and Key Managerial Personnel, effective October 30, 2026. Concurrently, Smt. Vibha Thakkar has been appointed as the new CFO and Key Managerial Personnel, effective October 31, 2026. Smt. Thakkar brings over 18 years of experience in finance across various industries.
Key Highlights
- Board approved unaudited financial results for Q2 FY27.
- Resignation of CFO Shri. Piyush Lakhani accepted.
- Smt. Vibha Thakkar appointed as new CFO.
- New CFO appointment effective October 31, 2026.
- Limited Review Report by Statutory Auditors enclosed.
Price Impact
More from AARTIPHARM